par Kennes, Bernard ;De Maubeuge, Josiane;Delespesse, Guy
Référence Clinical and experimental allergy, 7, 1, page (35-39)
Publication Publié, 1977
Article révisé par les pairs
Résumé : Twenty‐four patients with chronic urticaria resistant to conventional therapy were treated orally with terbutaline, a specific β2 stimulant. This therapy was much more effective than antihistamines. At the dose of 1.25 mg three times a day, there were few side effects. The efficacy was independent of the IgE levels; it seemed greater in idiopathic cases than in cholinergic or pressure induced urticaria. Copyright © 1977, Wiley Blackwell. All rights reserved